Clearer guidelines expected for drug labels

03/28/2005 | Boston Globe (tiered subscription model), The

The FDA estimates current obtuse labels on prescription drugs are leading to $3.8 billion in unnecessary hospital costs because of incorrect drug use, one of several reasons behind the agency's work on guidelines it hopes will lead to labels that are clearer to physicians and consumers. The agency expects to issue the guidelines within weeks as part of an effort to ensure all parties better understand the text on a container of medicine and the paperwork that accompanies it.

View Full Article in:

Boston Globe (tiered subscription model), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA
Food Lawyer
Cargill
Wayzata, MN
Director of Clinical Research
Regenesis Biomedical, Inc.
Scottsdale, AZ
Actuary
Meridian Health Plan
Detroit, MI
Assistant Vice President - Dental Director
MetLife
Bridgewater, NJ